Laurie J. Hall Trustee’s Takeda Pharmaceutical TAK Stock Holding History

Laurie J. Hall Trustee’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-619	Closed	-$8K	–	222
2024 Q4	$8K	Hold	619	–	–	﹤0.01%	235
2024 Q3	$9K	Buy	+619	New	+$8.78K	﹤0.01%	241

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Laurie J. Hall Trustee's TAK Position: Q1 2025 in Review

Laurie J. Hall Trustee sold out of Takeda Pharmaceutical (TAK) in Q1 2025, closing a stake of 619 shares — an estimated $8K sold.

Laurie J. Hall Trustee first reported a position in TAK in Q3 2024 and held it in 2 quarters. The position peaked at $9K in Q3 2024. 307 funds tracked by Wall St. Rank hold TAK as of Q1 2025.

Laurie J. Hall Trustee reported no remaining Takeda Pharmaceutical position as of Q1 2025 after selling out during the quarter.
Laurie J. Hall Trustee sold 619 Takeda Pharmaceutical shares in Q1 2025, an estimated $8K.
Laurie J. Hall Trustee first reported a position in Takeda Pharmaceutical in Q3 2024 and held it in 2 quarters.
Laurie J. Hall Trustee's Takeda Pharmaceutical position peaked at $9K in Q3 2024.
307 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2025.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2025, filed 15 May 2025.